Genuine Parts Co. closed 29.92% below its 52-week high of $164.45, which the company reached on April 18th.

Exicure, Inc. (Nasdaq: XCUR) today shared updates on its lead asset, GPC-100 (burixafor), a small molecule CXCR4 inhibitor. Exicure, Inc. ("Exicure") is planning for a clinical trial in Acute Myeloid ...

Fintel reports that on April 4, 2025, Evercore ISI Group upgraded their outlook for Genuine Parts (NYSE:GPC) from In-Line to ...

Fintel reports that on April 1, 2025, Goldman Sachs downgraded their outlook for Genuine Parts (NYSE:GPC) from Neutral to ...

Thrivent Financial for Lutherans lowered its stake in shares of Genuine Parts (NYSE:GPC – Free Report) by 78.9% during the ...

A major European polymer producer has turned to Testa Analytical’s COMBO-ONE detector to uncover subtle but significant ...

Research details hyaluronic acid's properties through SEC-MALS and differential viscometry, highlighting its molecular weight ...

Genuine Parts (NYSE:GPC – Free Report) had its price objective hoisted by Evercore ISI from $125.00 to $128.00 in a report ...

Genuine Parts Co. closed 27.83% short of its 52-week high of $164.45, which the company achieved on April 18th.

There will be £969 million of new investment into the contract – comprising £889m additional core contract funding and £80m ...

AW: Why is cybersecurity such an important topic to discuss in the aerospace and defense industry (A&D)? LB: Cybersecurity is ...